nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—PTGS2—lung cancer	0.292	1	CbGaD
Tetrahydrobiopterin—NOS3—Doxorubicin—lung cancer	0.259	0.732	CbGbCtD
Tetrahydrobiopterin—PTGS2—Cisplatin—lung cancer	0.0479	0.135	CbGbCtD
Tetrahydrobiopterin—PTGS2—Etoposide—lung cancer	0.0471	0.133	CbGbCtD
Tetrahydrobiopterin—NOS3—pulmonary artery—lung cancer	0.0181	0.354	CbGeAlD
Tetrahydrobiopterin—NOS3—umbilical vein—lung cancer	0.012	0.234	CbGeAlD
Tetrahydrobiopterin—NOS3—mammary gland—lung cancer	0.00458	0.0894	CbGeAlD
Tetrahydrobiopterin—NOS3—respiratory system—lung cancer	0.00305	0.0596	CbGeAlD
Tetrahydrobiopterin—NOS3—epithelium—lung cancer	0.00255	0.0498	CbGeAlD
Tetrahydrobiopterin—NOS3—trachea—lung cancer	0.00225	0.044	CbGeAlD
Tetrahydrobiopterin—NOS3—lung—lung cancer	0.00162	0.0316	CbGeAlD
Tetrahydrobiopterin—TH—lymph node—lung cancer	0.00123	0.024	CbGeAlD
Tetrahydrobiopterin—NOS3—lymph node—lung cancer	0.00111	0.0216	CbGeAlD
Tetrahydrobiopterin—PTGS2—respiratory system—lung cancer	0.000967	0.0189	CbGeAlD
Tetrahydrobiopterin—PTGS2—epithelium—lung cancer	0.000808	0.0158	CbGeAlD
Tetrahydrobiopterin—PTGS2—bronchus—lung cancer	0.000796	0.0155	CbGeAlD
Tetrahydrobiopterin—PTGS2—trachea—lung cancer	0.000714	0.014	CbGeAlD
Tetrahydrobiopterin—PTGS2—bone marrow—lung cancer	0.000567	0.0111	CbGeAlD
Tetrahydrobiopterin—PTGS2—lung—lung cancer	0.000513	0.01	CbGeAlD
Tetrahydrobiopterin—PTGS2—lymph node—lung cancer	0.000351	0.00686	CbGeAlD
Tetrahydrobiopterin—Urinary tract infection—Paclitaxel—lung cancer	0.00032	0.00217	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Gemcitabine—lung cancer	0.000318	0.00216	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Erlotinib—lung cancer	0.000317	0.00215	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Topotecan—lung cancer	0.000315	0.00213	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Teniposide—lung cancer	0.000313	0.00212	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Vinorelbine—lung cancer	0.000312	0.00212	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Erlotinib—lung cancer	0.000311	0.00211	CcSEcCtD
Tetrahydrobiopterin—Rash—Teniposide—lung cancer	0.00031	0.0021	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Teniposide—lung cancer	0.00031	0.0021	CcSEcCtD
Tetrahydrobiopterin—Infection—Vinorelbine—lung cancer	0.00031	0.0021	CcSEcCtD
Tetrahydrobiopterin—Headache—Teniposide—lung cancer	0.000308	0.00209	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Vinblastine—lung cancer	0.000307	0.00208	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Vinorelbine—lung cancer	0.000306	0.00207	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Vinorelbine—lung cancer	0.000303	0.00205	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Topotecan—lung cancer	0.000298	0.00202	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Methotrexate—lung cancer	0.000297	0.00201	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Vinblastine—lung cancer	0.000297	0.00201	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Cisplatin—lung cancer	0.000296	0.00201	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Erlotinib—lung cancer	0.000295	0.002	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Paclitaxel—lung cancer	0.000293	0.00199	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Docetaxel—lung cancer	0.000292	0.00198	CcSEcCtD
Tetrahydrobiopterin—Nausea—Teniposide—lung cancer	0.000292	0.00198	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Paclitaxel—lung cancer	0.000291	0.00197	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Topotecan—lung cancer	0.000288	0.00195	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Topotecan—lung cancer	0.000288	0.00195	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Cisplatin—lung cancer	0.000286	0.00194	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Erlotinib—lung cancer	0.000285	0.00193	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Erlotinib—lung cancer	0.000285	0.00193	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000284	0.00193	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Docetaxel—lung cancer	0.000279	0.00189	CcSEcCtD
Tetrahydrobiopterin—Infestation—Docetaxel—lung cancer	0.000279	0.00189	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Vinblastine—lung cancer	0.000276	0.00188	CcSEcCtD
Tetrahydrobiopterin—Cough—Irinotecan—lung cancer	0.000275	0.00187	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Docetaxel—lung cancer	0.000275	0.00186	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Docetaxel—lung cancer	0.000273	0.00185	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Etoposide—lung cancer	0.000271	0.00184	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000269	0.00183	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Topotecan—lung cancer	0.000269	0.00182	CcSEcCtD
Tetrahydrobiopterin—Cough—Gemcitabine—lung cancer	0.000268	0.00182	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Paclitaxel—lung cancer	0.000266	0.0018	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Gemcitabine—lung cancer	0.000261	0.00177	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000259	0.00176	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Irinotecan—lung cancer	0.000257	0.00174	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Paclitaxel—lung cancer	0.000257	0.00174	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Vinblastine—lung cancer	0.000257	0.00174	CcSEcCtD
Tetrahydrobiopterin—Infection—Irinotecan—lung cancer	0.000255	0.00173	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Vinorelbine—lung cancer	0.000255	0.00173	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Irinotecan—lung cancer	0.000252	0.00171	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Gemcitabine—lung cancer	0.00025	0.0017	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Topotecan—lung cancer	0.000249	0.00169	CcSEcCtD
Tetrahydrobiopterin—Infection—Gemcitabine—lung cancer	0.000249	0.00169	CcSEcCtD
Tetrahydrobiopterin—Irritability—Methotrexate—lung cancer	0.000249	0.00169	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Docetaxel—lung cancer	0.000248	0.00168	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Vinblastine—lung cancer	0.000248	0.00168	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Cisplatin—lung cancer	0.000248	0.00168	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Erlotinib—lung cancer	0.000247	0.00167	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Vinorelbine—lung cancer	0.000246	0.00167	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Vinorelbine—lung cancer	0.000246	0.00167	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Docetaxel—lung cancer	0.000246	0.00167	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Gemcitabine—lung cancer	0.000246	0.00167	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Gemcitabine—lung cancer	0.000243	0.00165	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000242	0.00164	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Topotecan—lung cancer	0.000241	0.00164	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Vinblastine—lung cancer	0.000239	0.00162	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Erlotinib—lung cancer	0.000238	0.00162	CcSEcCtD
Tetrahydrobiopterin—Agitation—Paclitaxel—lung cancer	0.000236	0.0016	CcSEcCtD
Tetrahydrobiopterin—Headache—Vinblastine—lung cancer	0.000235	0.00159	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Cisplatin—lung cancer	0.000233	0.00158	CcSEcCtD
Tetrahydrobiopterin—Infection—Cisplatin—lung cancer	0.000232	0.00157	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Topotecan—lung cancer	0.000232	0.00157	CcSEcCtD
Tetrahydrobiopterin—Rash—Topotecan—lung cancer	0.00023	0.00156	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Vinorelbine—lung cancer	0.00023	0.00156	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Topotecan—lung cancer	0.00023	0.00156	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Erlotinib—lung cancer	0.000229	0.00156	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Cisplatin—lung cancer	0.000229	0.00155	CcSEcCtD
Tetrahydrobiopterin—Cough—Etoposide—lung cancer	0.000229	0.00155	CcSEcCtD
Tetrahydrobiopterin—Headache—Topotecan—lung cancer	0.000228	0.00155	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000228	0.00155	CcSEcCtD
Tetrahydrobiopterin—Rash—Erlotinib—lung cancer	0.000227	0.00154	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Erlotinib—lung cancer	0.000227	0.00154	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Etoposide—lung cancer	0.000227	0.00154	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Cisplatin—lung cancer	0.000227	0.00154	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Irinotecan—lung cancer	0.000226	0.00154	CcSEcCtD
Tetrahydrobiopterin—Headache—Erlotinib—lung cancer	0.000226	0.00153	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	0.000226	0.00153	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Docetaxel—lung cancer	0.000225	0.00153	CcSEcCtD
Tetrahydrobiopterin—Cough—Paclitaxel—lung cancer	0.000224	0.00152	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vinblastine—lung cancer	0.000223	0.00151	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Paclitaxel—lung cancer	0.000223	0.00151	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Irinotecan—lung cancer	0.000222	0.00151	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000222	0.0015	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Paclitaxel—lung cancer	0.000219	0.00148	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Docetaxel—lung cancer	0.000218	0.00148	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000217	0.00147	CcSEcCtD
Tetrahydrobiopterin—Nausea—Topotecan—lung cancer	0.000216	0.00147	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000216	0.00147	CcSEcCtD
Tetrahydrobiopterin—Nausea—Erlotinib—lung cancer	0.000214	0.00145	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Etoposide—lung cancer	0.000214	0.00145	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Vinorelbine—lung cancer	0.000213	0.00145	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000213	0.00144	CcSEcCtD
Tetrahydrobiopterin—Infection—Etoposide—lung cancer	0.000212	0.00144	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Methotrexate—lung cancer	0.000211	0.00143	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Irinotecan—lung cancer	0.00021	0.00143	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Paclitaxel—lung cancer	0.00021	0.00142	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Methotrexate—lung cancer	0.000209	0.00142	CcSEcCtD
Tetrahydrobiopterin—Infection—Paclitaxel—lung cancer	0.000208	0.00141	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Etoposide—lung cancer	0.000208	0.00141	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Vinorelbine—lung cancer	0.000206	0.0014	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Doxorubicin—lung cancer	0.000206	0.0014	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Paclitaxel—lung cancer	0.000206	0.0014	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Paclitaxel—lung cancer	0.000204	0.00138	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Irinotecan—lung cancer	0.000203	0.00138	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Irinotecan—lung cancer	0.000203	0.00138	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Doxorubicin—lung cancer	0.000202	0.00137	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Cisplatin—lung cancer	0.000202	0.00137	CcSEcCtD
Tetrahydrobiopterin—Infestation—Methotrexate—lung cancer	0.000201	0.00136	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Methotrexate—lung cancer	0.000201	0.00136	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Doxorubicin—lung cancer	0.0002	0.00136	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Vinorelbine—lung cancer	0.000198	0.00134	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Gemcitabine—lung cancer	0.000198	0.00134	CcSEcCtD
Tetrahydrobiopterin—Rash—Vinorelbine—lung cancer	0.000197	0.00133	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Vinorelbine—lung cancer	0.000196	0.00133	CcSEcCtD
Tetrahydrobiopterin—Headache—Vinorelbine—lung cancer	0.000195	0.00133	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000191	0.0013	CcSEcCtD
Tetrahydrobiopterin—Cough—Docetaxel—lung cancer	0.00019	0.00129	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Irinotecan—lung cancer	0.000189	0.00129	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Docetaxel—lung cancer	0.000189	0.00128	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Docetaxel—lung cancer	0.000185	0.00126	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vinorelbine—lung cancer	0.000185	0.00126	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Etoposide—lung cancer	0.000185	0.00125	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Paclitaxel—lung cancer	0.000185	0.00125	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Cisplatin—lung cancer	0.000185	0.00125	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000184	0.00125	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Doxorubicin—lung cancer	0.000182	0.00124	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000181	0.00123	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000181	0.00123	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Methotrexate—lung cancer	0.000179	0.00121	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Docetaxel—lung cancer	0.000178	0.00121	CcSEcCtD
Tetrahydrobiopterin—Infection—Docetaxel—lung cancer	0.000177	0.0012	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Irinotecan—lung cancer	0.000176	0.00119	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Etoposide—lung cancer	0.000175	0.00119	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Docetaxel—lung cancer	0.000174	0.00118	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Doxorubicin—lung cancer	0.000174	0.00118	CcSEcCtD
Tetrahydrobiopterin—Infestation—Doxorubicin—lung cancer	0.000174	0.00118	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Docetaxel—lung cancer	0.000173	0.00117	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Cisplatin—lung cancer	0.000172	0.00117	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000171	0.00116	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Gemcitabine—lung cancer	0.000171	0.00116	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Irinotecan—lung cancer	0.00017	0.00115	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Etoposide—lung cancer	0.000169	0.00115	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Etoposide—lung cancer	0.000169	0.00115	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Doxorubicin—lung cancer	0.000169	0.00115	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Paclitaxel—lung cancer	0.000166	0.00112	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Paclitaxel—lung cancer	0.000166	0.00112	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Irinotecan—lung cancer	0.000163	0.00111	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Methotrexate—lung cancer	0.000163	0.0011	CcSEcCtD
Tetrahydrobiopterin—Rash—Irinotecan—lung cancer	0.000162	0.0011	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Irinotecan—lung cancer	0.000162	0.0011	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000162	0.0011	CcSEcCtD
Tetrahydrobiopterin—Headache—Irinotecan—lung cancer	0.000161	0.00109	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Cisplatin—lung cancer	0.00016	0.00108	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Gemcitabine—lung cancer	0.000159	0.00108	CcSEcCtD
Tetrahydrobiopterin—Rash—Gemcitabine—lung cancer	0.000158	0.00107	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Gemcitabine—lung cancer	0.000158	0.00107	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Etoposide—lung cancer	0.000158	0.00107	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Methotrexate—lung cancer	0.000157	0.00106	CcSEcCtD
Tetrahydrobiopterin—Headache—Gemcitabine—lung cancer	0.000157	0.00106	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Docetaxel—lung cancer	0.000156	0.00106	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Doxorubicin—lung cancer	0.000155	0.00105	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Paclitaxel—lung cancer	0.000155	0.00105	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Doxorubicin—lung cancer	0.000154	0.00104	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Docetaxel—lung cancer	0.000153	0.00104	CcSEcCtD
Tetrahydrobiopterin—Nausea—Irinotecan—lung cancer	0.000153	0.00104	CcSEcCtD
Tetrahydrobiopterin—Nausea—Gemcitabine—lung cancer	0.000149	0.00101	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Cisplatin—lung cancer	0.000148	0.00101	CcSEcCtD
Tetrahydrobiopterin—Rash—Cisplatin—lung cancer	0.000147	0.000999	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Cisplatin—lung cancer	0.000147	0.000998	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Etoposide—lung cancer	0.000146	0.000993	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Docetaxel—lung cancer	0.000145	0.000986	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Paclitaxel—lung cancer	0.000143	0.000973	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Etoposide—lung cancer	0.000141	0.00096	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Doxorubicin—lung cancer	0.000141	0.000955	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Docetaxel—lung cancer	0.000141	0.000953	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Docetaxel—lung cancer	0.000141	0.000953	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Paclitaxel—lung cancer	0.000139	0.000941	CcSEcCtD
Tetrahydrobiopterin—Nausea—Cisplatin—lung cancer	0.000139	0.000941	CcSEcCtD
Tetrahydrobiopterin—Cough—Methotrexate—lung cancer	0.000137	0.000929	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Methotrexate—lung cancer	0.000136	0.000923	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Etoposide—lung cancer	0.000136	0.000923	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Doxorubicin—lung cancer	0.000136	0.000922	CcSEcCtD
Tetrahydrobiopterin—Rash—Etoposide—lung cancer	0.000135	0.000915	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Etoposide—lung cancer	0.000135	0.000914	CcSEcCtD
Tetrahydrobiopterin—Headache—Etoposide—lung cancer	0.000134	0.000909	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Methotrexate—lung cancer	0.000134	0.000907	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Paclitaxel—lung cancer	0.000133	0.000905	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000133	0.0009	CcSEcCtD
Tetrahydrobiopterin—Rash—Paclitaxel—lung cancer	0.000132	0.000897	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Paclitaxel—lung cancer	0.000132	0.000896	CcSEcCtD
Tetrahydrobiopterin—Headache—Paclitaxel—lung cancer	0.000131	0.000891	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Docetaxel—lung cancer	0.000131	0.000888	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Methotrexate—lung cancer	0.000128	0.000869	CcSEcCtD
Tetrahydrobiopterin—Infection—Methotrexate—lung cancer	0.000127	0.000863	CcSEcCtD
Tetrahydrobiopterin—Nausea—Etoposide—lung cancer	0.000127	0.000862	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Methotrexate—lung cancer	0.000126	0.000852	CcSEcCtD
Tetrahydrobiopterin—Agitation—Doxorubicin—lung cancer	0.000125	0.000847	CcSEcCtD
Tetrahydrobiopterin—Nausea—Paclitaxel—lung cancer	0.000125	0.000845	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Methotrexate—lung cancer	0.000124	0.000844	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Docetaxel—lung cancer	0.000122	0.000825	CcSEcCtD
Tetrahydrobiopterin—Cough—Doxorubicin—lung cancer	0.000119	0.000805	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Doxorubicin—lung cancer	0.000118	0.000799	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Docetaxel—lung cancer	0.000118	0.000797	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000117	0.000792	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Doxorubicin—lung cancer	0.000116	0.000785	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000115	0.00078	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Docetaxel—lung cancer	0.000113	0.000767	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Methotrexate—lung cancer	0.000113	0.000765	CcSEcCtD
Tetrahydrobiopterin—Rash—Docetaxel—lung cancer	0.000112	0.00076	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Docetaxel—lung cancer	0.000112	0.00076	CcSEcCtD
Tetrahydrobiopterin—Headache—Docetaxel—lung cancer	0.000111	0.000755	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Doxorubicin—lung cancer	0.000111	0.000753	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Methotrexate—lung cancer	0.000111	0.00075	CcSEcCtD
Tetrahydrobiopterin—Infection—Doxorubicin—lung cancer	0.00011	0.000748	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Doxorubicin—lung cancer	0.000109	0.000738	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Doxorubicin—lung cancer	0.000108	0.000731	CcSEcCtD
Tetrahydrobiopterin—Nausea—Docetaxel—lung cancer	0.000106	0.000716	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Methotrexate—lung cancer	0.000105	0.000711	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Methotrexate—lung cancer	0.000101	0.000687	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Methotrexate—lung cancer	0.000101	0.000687	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000101	0.000686	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Doxorubicin—lung cancer	9.76e-05	0.000662	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Doxorubicin—lung cancer	9.58e-05	0.00065	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Methotrexate—lung cancer	9.44e-05	0.00064	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Doxorubicin—lung cancer	9.07e-05	0.000615	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Doxorubicin—lung cancer	8.77e-05	0.000595	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Doxorubicin—lung cancer	8.77e-05	0.000595	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Methotrexate—lung cancer	8.77e-05	0.000595	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Methotrexate—lung cancer	8.47e-05	0.000575	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Doxorubicin—lung cancer	8.17e-05	0.000554	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Methotrexate—lung cancer	8.15e-05	0.000553	CcSEcCtD
Tetrahydrobiopterin—Rash—Methotrexate—lung cancer	8.08e-05	0.000548	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Methotrexate—lung cancer	8.07e-05	0.000548	CcSEcCtD
Tetrahydrobiopterin—Headache—Methotrexate—lung cancer	8.03e-05	0.000544	CcSEcCtD
Tetrahydrobiopterin—Nausea—Methotrexate—lung cancer	7.61e-05	0.000516	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Doxorubicin—lung cancer	7.59e-05	0.000515	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Doxorubicin—lung cancer	7.34e-05	0.000498	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Doxorubicin—lung cancer	7.05e-05	0.000479	CcSEcCtD
Tetrahydrobiopterin—Rash—Doxorubicin—lung cancer	6.99e-05	0.000475	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Doxorubicin—lung cancer	6.99e-05	0.000474	CcSEcCtD
Tetrahydrobiopterin—Headache—Doxorubicin—lung cancer	6.95e-05	0.000471	CcSEcCtD
Tetrahydrobiopterin—Nausea—Doxorubicin—lung cancer	6.59e-05	0.000447	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—PIK3CG—lung cancer	2.62e-05	0.000168	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SDC4—lung cancer	2.62e-05	0.000168	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CAT—lung cancer	2.59e-05	0.000166	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TERT—lung cancer	2.57e-05	0.000165	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3CB—lung cancer	2.56e-05	0.000164	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—MAPK3—lung cancer	2.53e-05	0.000163	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTGS2—lung cancer	2.53e-05	0.000163	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	2.52e-05	0.000162	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ABCB1—lung cancer	2.52e-05	0.000162	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—EP300—lung cancer	2.52e-05	0.000161	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—FGFR1—lung cancer	2.5e-05	0.00016	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—POMC—lung cancer	2.49e-05	0.00016	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—TYMS—lung cancer	2.47e-05	0.000159	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HIF1A—lung cancer	2.46e-05	0.000158	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	2.45e-05	0.000157	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GSTM1—lung cancer	2.45e-05	0.000157	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—SRC—lung cancer	2.45e-05	0.000157	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—CREBBP—lung cancer	2.43e-05	0.000156	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL6—lung cancer	2.43e-05	0.000156	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—STK11—lung cancer	2.41e-05	0.000154	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PXN—lung cancer	2.39e-05	0.000154	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	2.39e-05	0.000153	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—RRM1—lung cancer	2.38e-05	0.000153	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTA3—lung cancer	2.38e-05	0.000153	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—APOA1—lung cancer	2.38e-05	0.000152	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—STAT3—lung cancer	2.36e-05	0.000151	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NRAS—lung cancer	2.35e-05	0.000151	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKR1C1—lung cancer	2.34e-05	0.00015	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FOXO3—lung cancer	2.32e-05	0.000149	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CYP1A1—lung cancer	2.32e-05	0.000149	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CD—lung cancer	2.3e-05	0.000148	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ERCC2—lung cancer	2.3e-05	0.000148	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—KRAS—lung cancer	2.28e-05	0.000146	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ALB—lung cancer	2.27e-05	0.000146	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	2.26e-05	0.000145	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MAPK3—lung cancer	2.25e-05	0.000145	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—B4GALT5—lung cancer	2.24e-05	0.000144	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTEN—lung cancer	2.21e-05	0.000142	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	2.2e-05	0.000141	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MYC—lung cancer	2.19e-05	0.000141	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTA4—lung cancer	2.18e-05	0.00014	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AVP—lung cancer	2.18e-05	0.00014	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KIT—lung cancer	2.17e-05	0.000139	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—APC—lung cancer	2.17e-05	0.000139	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NPPA—lung cancer	2.16e-05	0.000138	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	2.15e-05	0.000138	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—EGFR—lung cancer	2.14e-05	0.000138	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EGF—lung cancer	2.14e-05	0.000138	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PIK3CA—lung cancer	2.13e-05	0.000137	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.13e-05	0.000137	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTA2—lung cancer	2.12e-05	0.000136	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—EP300—lung cancer	2.11e-05	0.000135	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PPIA—lung cancer	2.1e-05	0.000135	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF1R—lung cancer	2.09e-05	0.000134	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PIK3CA—lung cancer	2.09e-05	0.000134	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ALDOA—lung cancer	2.09e-05	0.000134	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HES1—lung cancer	2.06e-05	0.000132	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTA1—lung cancer	2.05e-05	0.000131	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—BRAF—lung cancer	2.04e-05	0.000131	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	2.03e-05	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCC3—lung cancer	2.03e-05	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—KRAS—lung cancer	2.03e-05	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—lung cancer	2.02e-05	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6R—lung cancer	2.01e-05	0.000129	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CREBBP—lung cancer	2.01e-05	0.000129	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CB—lung cancer	2.01e-05	0.000129	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—APOA1—lung cancer	1.99e-05	0.000128	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—lung cancer	1.99e-05	0.000128	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ADCY1—lung cancer	1.97e-05	0.000127	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AKR1C1—lung cancer	1.96e-05	0.000126	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—HRAS—lung cancer	1.94e-05	0.000124	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ENO2—lung cancer	1.93e-05	0.000124	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PPP2R1B—lung cancer	1.92e-05	0.000123	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SMARCA4—lung cancer	1.92e-05	0.000123	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MAP2K1—lung cancer	1.92e-05	0.000123	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CD—lung cancer	1.91e-05	0.000122	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—UGT1A1—lung cancer	1.9e-05	0.000122	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB3—lung cancer	1.88e-05	0.000121	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.87e-05	0.00012	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PIK3CA—lung cancer	1.86e-05	0.000119	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GNG11—lung cancer	1.84e-05	0.000118	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.83e-05	0.000117	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CG—lung cancer	1.82e-05	0.000117	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.8e-05	0.000116	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TERT—lung cancer	1.8e-05	0.000116	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ENO1—lung cancer	1.76e-05	0.000113	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FGFR1—lung cancer	1.75e-05	0.000112	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ALDOA—lung cancer	1.75e-05	0.000112	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—AKT1—lung cancer	1.74e-05	0.000112	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTEN—lung cancer	1.73e-05	0.000111	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—POMC—lung cancer	1.73e-05	0.000111	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HIF1A—lung cancer	1.72e-05	0.000111	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HRAS—lung cancer	1.72e-05	0.00011	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—AKT1—lung cancer	1.71e-05	0.00011	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MDM2—lung cancer	1.71e-05	0.00011	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—RAF1—lung cancer	1.7e-05	0.000109	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOA3—lung cancer	1.7e-05	0.000109	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CREBBP—lung cancer	1.68e-05	0.000108	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ERBB2—lung cancer	1.68e-05	0.000108	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.67e-05	0.000107	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APOA1—lung cancer	1.66e-05	0.000107	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MTOR—lung cancer	1.66e-05	0.000107	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CB—lung cancer	1.66e-05	0.000107	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CD4—lung cancer	1.66e-05	0.000106	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—EP300—lung cancer	1.65e-05	0.000106	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCG2—lung cancer	1.65e-05	0.000106	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ADCY1—lung cancer	1.65e-05	0.000106	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KDR—lung cancer	1.65e-05	0.000106	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—IL6—lung cancer	1.65e-05	0.000106	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—lung cancer	1.65e-05	0.000106	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APP—lung cancer	1.63e-05	0.000105	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGF9—lung cancer	1.62e-05	0.000104	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HPGDS—lung cancer	1.62e-05	0.000104	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ENO2—lung cancer	1.62e-05	0.000104	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPP2R1B—lung cancer	1.61e-05	0.000103	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CD—lung cancer	1.6e-05	0.000102	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.59e-05	0.000102	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ALB—lung cancer	1.58e-05	0.000101	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTT1—lung cancer	1.57e-05	0.000101	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3CA—lung cancer	1.56e-05	0.0001	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GCLC—lung cancer	1.55e-05	9.96e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP2A6—lung cancer	1.55e-05	9.96e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—JUNB—lung cancer	1.55e-05	9.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.55e-05	9.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.52e-05	9.78e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—AKT1—lung cancer	1.52e-05	9.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CG—lung cancer	1.52e-05	9.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KIT—lung cancer	1.52e-05	9.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APC—lung cancer	1.52e-05	9.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGF—lung cancer	1.5e-05	9.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ENO1—lung cancer	1.47e-05	9.44e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.47e-05	9.41e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.45e-05	9.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—POMC—lung cancer	1.45e-05	9.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN1A—lung cancer	1.44e-05	9.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTEN—lung cancer	1.44e-05	9.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—BRAF—lung cancer	1.43e-05	9.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6R—lung cancer	1.41e-05	9.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CREBBP—lung cancer	1.41e-05	9.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CB—lung cancer	1.39e-05	8.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—lung cancer	1.38e-05	8.85e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EP300—lung cancer	1.37e-05	8.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FOXO3—lung cancer	1.36e-05	8.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAP2K1—lung cancer	1.34e-05	8.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CD—lung cancer	1.34e-05	8.57e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SRC—lung cancer	1.33e-05	8.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP2E1—lung cancer	1.32e-05	8.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NQO1—lung cancer	1.31e-05	8.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—STAT3—lung cancer	1.28e-05	8.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NRAS—lung cancer	1.28e-05	8.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.28e-05	8.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—AKT1—lung cancer	1.27e-05	8.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MAPK3—lung cancer	1.23e-05	7.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CA—lung cancer	1.22e-05	7.85e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTEN—lung cancer	1.2e-05	7.72e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HES1—lung cancer	1.2e-05	7.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MDM2—lung cancer	1.2e-05	7.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MYC—lung cancer	1.19e-05	7.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RAF1—lung cancer	1.19e-05	7.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB2—lung cancer	1.18e-05	7.57e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—STK11—lung cancer	1.18e-05	7.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EGFR—lung cancer	1.17e-05	7.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MTOR—lung cancer	1.16e-05	7.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CB—lung cancer	1.16e-05	7.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—EP300—lung cancer	1.15e-05	7.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERCC2—lung cancer	1.12e-05	7.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CXCL8—lung cancer	1.12e-05	7.18e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.1e-05	7.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KRAS—lung cancer	1.1e-05	7.08e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB3—lung cancer	1.1e-05	7.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTP1—lung cancer	1.09e-05	6.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CASP3—lung cancer	1.07e-05	6.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL2—lung cancer	1.07e-05	6.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CAT—lung cancer	1.06e-05	6.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.05e-05	6.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TERT—lung cancer	1.05e-05	6.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCND1—lung cancer	1.04e-05	6.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—JUN—lung cancer	1.04e-05	6.67e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCB1—lung cancer	1.03e-05	6.61e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGFR1—lung cancer	1.02e-05	6.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CA—lung cancer	1.01e-05	6.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TYMS—lung cancer	1.01e-05	6.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP9—lung cancer	1.01e-05	6.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN1A—lung cancer	1.01e-05	6.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HIF1A—lung cancer	1.01e-05	6.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTEN—lung cancer	1.01e-05	6.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTM1—lung cancer	1e-05	6.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—AKT1—lung cancer	1e-05	6.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APOA1—lung cancer	9.71e-06	6.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EP300—lung cancer	9.59e-06	6.15e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP1A1—lung cancer	9.48e-06	6.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ERCC2—lung cancer	9.4e-06	6.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HRAS—lung cancer	9.37e-06	6.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SRC—lung cancer	9.33e-06	5.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VEGFA—lung cancer	9.08e-06	5.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—STAT3—lung cancer	8.99e-06	5.77e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NRAS—lung cancer	8.97e-06	5.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6—lung cancer	8.97e-06	5.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APC—lung cancer	8.87e-06	5.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KIT—lung cancer	8.87e-06	5.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGF—lung cancer	8.77e-06	5.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAPK3—lung cancer	8.59e-06	5.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CA—lung cancer	8.48e-06	5.44e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MYC—lung cancer	8.36e-06	5.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—BRAF—lung cancer	8.34e-06	5.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—AKT1—lung cancer	8.28e-06	5.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6R—lung cancer	8.24e-06	5.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CREBBP—lung cancer	8.22e-06	5.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGFR—lung cancer	8.17e-06	5.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—APOA1—lung cancer	8.14e-06	5.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAP2K1—lung cancer	7.85e-06	5.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CD—lung cancer	7.8e-06	5e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.79e-06	5e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KRAS—lung cancer	7.72e-06	4.96e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CG—lung cancer	7.43e-06	4.77e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CA—lung cancer	7.09e-06	4.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—POMC—lung cancer	7.07e-06	4.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MDM2—lung cancer	6.98e-06	4.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RAF1—lung cancer	6.96e-06	4.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AKT1—lung cancer	6.93e-06	4.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CREBBP—lung cancer	6.89e-06	4.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB2—lung cancer	6.89e-06	4.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—lung cancer	6.86e-06	4.4e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CB—lung cancer	6.8e-06	4.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTOR—lung cancer	6.8e-06	4.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD4—lung cancer	6.78e-06	4.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HRAS—lung cancer	6.56e-06	4.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CD—lung cancer	6.53e-06	4.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ALB—lung cancer	6.45e-06	4.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6—lung cancer	6.28e-06	4.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN1A—lung cancer	5.89e-06	3.78e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PTEN—lung cancer	5.87e-06	3.77e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT1—lung cancer	5.8e-06	3.72e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CB—lung cancer	5.69e-06	3.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EP300—lung cancer	5.6e-06	3.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SRC—lung cancer	5.45e-06	3.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—STAT3—lung cancer	5.25e-06	3.37e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NRAS—lung cancer	5.24e-06	3.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAPK3—lung cancer	5.02e-06	3.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PTEN—lung cancer	4.92e-06	3.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MYC—lung cancer	4.88e-06	3.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGFR—lung cancer	4.77e-06	3.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—EP300—lung cancer	4.69e-06	3.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KRAS—lung cancer	4.51e-06	2.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CA—lung cancer	4.14e-06	2.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HRAS—lung cancer	3.83e-06	2.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6—lung cancer	3.67e-06	2.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CA—lung cancer	3.47e-06	2.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT1—lung cancer	3.38e-06	2.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AKT1—lung cancer	2.83e-06	1.82e-05	CbGpPWpGaD
